The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

Published:2010-05 Issue:5 Volume:10 Page:1228-1237
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Humar A.,Lebranchu Y.,Vincenti F.,Blumberg E. A.,Punch J. D.,Limaye A. P.,Abramowicz D.,Jardine A. G.,Voulgari A. T.,Ives J.,Hauser I. A.,Peeters P.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2010.03074.x/fullpdf

Reference25 articles.

1. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: A collaborative transplant study report;Opelz;Am J Transplant,2004

2. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report;Preiksaitis;Am J Transplant,2005

3. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: The end of the ‘silo hypothesis’;Rubin;Curr Opin Infect Dis,2007

4. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection;Kranz;Pediatr Transplant,2008

Cited by 434 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation;Transplantation Direct;2024-07-26

3. Recommendations for the selection of nucleoside analogues as antihuman herpesvirus drugs: a real-world analysis of reported cases from the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-07-04

4. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18

5. Evaluation of Bispecific T-Cell Engagers Targeting Murine Cytomegalovirus;Viruses;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3